SFTBY - SoftBank Bets Big On AI In Healthcare: Inks New Joint Venture with Tempus To Transform Cancer Treatment In Japan | Benzinga
SoftBank Group Corp (OTC:SFTBF) has announced a new joint venture, SB TEMPUS Corp., with Tempus AI Inc (NASDAQ:TEM), aiming to enhance precision medicine in Japan using artificial intelligence.
The agreement was signed in May 2024, and the venture is set to launch in July 2024, with each party investing JPY 15.0 billion.
This collaboration seeks to revolutionize healthcare in Japan by leveraging Tempus’ AI expertise and technology.
Founded in 2015, Tempus uses AI to improve healthcare. The company’s platform is connected to around 50% of U.S. oncologists and boasts one of the largest libraries of de-identified molecular, clinical, and imaging ...